EYEN: Eyenovia, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.17
Enterprise Value ($M) 13.14
Book Value ($M) -13.10
Book Value / Share -4.63
Price / Book -0.24
NCAV ($M) -14.00
NCAV / Share -4.94
Price / NCAV -0.23

Profitability (mra)
Return on Invested Capital (ROIC) -173.93
Return on Assets (ROA) -1.90
Return on Equity (ROE) -27.41

Liquidity (mrq)
Quick Ratio -0.01
Current Ratio 0.17

Balance Sheet (mrq) ($M)
Current Assets 2.77
Assets 3.67
Liabilities 16.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.06
Operating Income -37.53
Net Income -49.82
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -30.12
Cash from Investing -0.16
Cash from Financing 17.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
12-04 13D/A Grant Stuart M. 3.96 -27.70
11-14 13G/A Armistice Capital, Llc 9.95 96.44
07-18 13D/A Ianchulev Tsontcho 3.20 -7.93

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-30 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A Amendment No. 1
2025-04-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-29 12,407 42,060 29.50
2025-04-28 8,677 22,748 38.14
2025-04-25 9,116 25,154 36.24
2025-04-24 12,817 45,883 27.93

(click for more detail)

Similar Companies
ERNA – Ernexa Therapeutics Inc. ESLA – Estrella Immunopharma, Inc.
EVOK – Evoke Pharma, Inc. FBIO – Fortress Biotech, Inc.
FBLG – FibroBiologics, Inc.


Financial data and stock pages provided by
Fintel.io



This entry was posted in . Bookmark the permalink.